If your doctor thinks you have an ulcer, you may have to swallow a special camera called an endoscope to find out for sure. The good news: in about a year doctors may be able to quickly and painlessly cure the ulcer at the same time, thanks to a device from Boston, MA-based startup LumeRx. The company is developing a fiber-optic device that can be passed into the stomach alongside the endoscope. In a procedure that takes only five to 10 minutes, the device beams out blue light specially tuned to kill a bacterium called Helicobacter pylori, which causes up to 90 percent of ulcers. Should the approach prove itself in human tests planned for this summer and gain U.S. Food and Drug Administration approval, it could offer an alternative to today’s standard ulcer treatment: a one- to two-week course of antibiotics that can cause nausea and other side effects and which could ultimately promote the development of resistant strains of bacteria.
Meta has built a massive new language AI—and it’s giving it away for free
Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.